查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球關節內置換療法市場
市場調查報告書
商品編碼
1153812

2022-2029 年全球關節內置換療法市場

Global Viscosupplementation Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球關節內置換療法的市場規模預計在 2022 年達到 453867 萬美元，在 2029 年達到 805834 萬美元，預測期內（2022-2029 年）的複合年增長率為 8.96%。據說會增長在

關節內置換療法是一種微創手術，其中將有助於滑液粘性的凝膠狀物質注入關節。旨在改善關節病患者的關節功能。透明質酸增加滑液的潤滑性，減輕膝骨關節炎的疼痛，並改善運動功能。

市場動態

骨關節炎和類風濕性關節炎發病率的上升、研究和開發的增加以及對緩解疼痛的關節內替代療法的需求不斷增加是推動全球關節內替代療法市場的主要因素。它是

骨關節炎患病率和發病率的上升以及技術的不斷進步預計將推動市場增長。

關節內替代療法市場受到技術進步、研究和開發增加以及骨關節炎關節內替代療法的高需求的推動，這也有望推動關節內替代療法市場。它有到過。市場增長也歸因於醫療保健和臨床試驗支出的增加。此外，預計主要製造商提供的技術先進的產品也將在市場增長中發揮重要作用。

增加政府補貼和提高對骨關節炎治療的認識將促進市場增長。關節內替代療法在骨關節炎疼痛管理中的高采用率也是關節內替代療法市場的驅動因素之一。各種新產品的發布和研究正在為市場的增長做出貢獻。

例如，2021 年 8 月，Seikagaku Corporation 從台灣 TCM Biotech International Corporation 推出了 Hilink，這是一種用於治療膝骨關節炎的單次注射關節內替代療法。這款HYLINK主要由生化學的交聯技術製成的交聯透明質酸水凝膠組成，用於治療膝骨關節炎。具有高粘彈性的透明質酸水凝膠有望通過長期停留在膝關節腔內來改善症狀。

與關節內置換療法相關的副作用預計會阻礙市場增長。

然而，使用關節內替代療法的副作用，例如腫脹和瘙癢、關節周圍瘀傷以及注射膝關節積液，正在阻礙全球關節內替代療法市場的增長。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。由於 COVID 病例的增加，各種研究和臨床試驗被推遲，關節內替代治療市場因 COVID 遭受了巨大損失。世界各地正在發生各種倡議、合作和合併，促進了市場的增長。例如，2021 年 12 月，Avanos Medical, Inc. 宣布達成協議，以約 1.6 億美元的價格收購 OrthogenRx Inc.，後者是膝關節骨性關節炎疼痛的關節內替代療法供應商。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 骨關節炎的患病率和發病率上升
      • 技術進步的增加
    • 約束因素
      • 相關副作用
    • 市場機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 流行病學

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按程序類型

  • 單次注射
  • 3 次注射
  • 5 注射

第八章應用

  • 膝蓋骨關節炎
  • 髖骨關節炎
  • 肩骨關節炎
  • 腳踝骨關節炎

第 9 章最終用戶

  • 骨科診所
  • 醫院
  • 門診手術中心

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • Anika Therapeutics, Inc.
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Seikagaku Corporation
  • Bioventus Inc.
  • Johnson and Johnson
  • Zimmer Biomet
  • Sanofi S.A.
  • Miravo Healthcare
  • Aptissen
  • L.G. Chem and Lifesciences Ltd
  • F. Hoffmann La Roche

第13章 全球關節內置換療法市場-DataM

簡介目錄
Product Code: DMPH1188

Market Overview

The global viscosupplementation market size was valued at US$ 4,538.67 million in 2022 and is estimated to reach US$ 8,058.34 million by 2029, growing at a CAGR of 8.96% during the forecast period (2022-2029).

Viscosupplementation is a minimally invasive procedure that involves the injection of gel-like substances into a joint to assist the viscous properties of synovial fluid in reducing the joint pain and improves the functional condition of osteoarthritis joints by using a thick fluid called hyaluronate is injected into the knee joint. Hyaluronate helps improve the lubricating properties of the synovial fluid, reduces the pain from osteoarthritis of the knee, and improves mobility.

Market Dynamics

The rising incidence of osteoarthritis and rheumatoid arthritis, increasing research and development, and rising demand for viscosupplementation for relieving pain are the major factors driving the global viscosupplementation market.

The rising prevalence & incidence of osteoarthritis and increasing technological advancements are expected to drive the market's growth.

The viscosupplementation market is driven by rising technological advancements, increasing research & development, and high demand for viscosupplementation in osteoarthritis, which is also expected to drive the viscosupplementation market. The market's growth can also be attributed to the rising expenditure on healthcare and clinical trials. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Rising government funding and increasing awareness of treating osteoarthritis will boost market growth. Another driving factor for the viscosupplementation market is the high adoption rate of viscosupplementation for osteoarthritis pain management. Various novel product launches and research studies contribute to the market's growth.

For instance, in Aug 2021, Seikagaku Corporation launched its Hylink, an intra-articular viscosupplement single injection for knee osteoarthritis treatment in Taiwan, by TCM Biotech International Corporation. This HyLink is used for knee osteoarthritis treatment as its main ingredient, cross-linked hyaluronate hydrogel, is made by crosslinking technology of Seikagaku. It is expected to show improvement in symptoms as highly viscoelastic hyaluronate hydrogel will remain in the joint cavity of the knee for a longer duration.

Side effects associated with viscosupplementation are expected to hamper market growth.

However, the side effects of using viscosupplementation, like swelling, itching, bruising around the joint, and fluid accumulation in the injected knee, hamper the global viscosupplementation market growth.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The Viscosupplementation market has experienced huge losses due to COVID, as various research and clinical trials got postponed due to the increasing cases of COVID. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Dec 2021, Avanos Medical, Inc. announced about its agreement to acquisition with OrthogenRx Inc., a viscosupplementation therapies provider for knee osteoarthritis pain, for around $160 million.

Segment Analysis

The knee osteoarthritis segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Knee osteoarthritis is a joint disorder that is slowly progressive that can be characterized by cartilage degeneration, joint pain, and inflammation; that affects around 350 million people globally. Knee osteoarthritis has various treatment options, from conservative management to knee arthroplasty. The most used non-operative therapies are intra-articular therapies like hyaluronic acid and corticosteroids. This intra-articular hyaluronic acid is the widely used therapy for treating knee pain and inflammation in people with knee osteoarthritis.

The knee osteoarthritis segment dominates the market due to rising global incidences of knee osteoarthritis and the increasing geriatric population. The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in Sep 2021, Bioventus Inc., an active healing innovation company, announced that the American Academy of Orthopaedic Surgeons released their updated clinical practice guidelines that show that Bioventus's DUROLANE treatment and all the high molecular weight cross-linked hyaluronic treatments have shown improvement in patients with knee osteoarthritis.

Geographical Analysis

North America holds the largest market share in the global viscosupplementation market.

North America dominates the global viscosupplementation market, primarily attributed to the rising number of people suffering from osteoarthritis. According to the Centre for Disease Control and Prevention, in 2020, over 32.5 million adults were dealing with osteoarthritis in the United States. Around 14 million people are suffering from rheumatoid arthritis globally. Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of technology in these viscosupplementations, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the viscosupplementation market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Jul 2022, Bioventus Inc., an active healing innovative company, announced its completion of the acquisition of CartiHeal. This acquisition adds CartHeal's active healing solutions portfolio to Bioventus.

Competitive Landscape

The viscosupplementation market is moderately competitive with local and global companies' presence. Anika Therapeutics, Inc., Seikagaku Corporation, Bioventus Inc., Johnson and Johnson, Zimmer Biomet, Sanofi S.A., Miravo Healthcare, Aptissen, L.G. Chem and Lifesciences Ltd, F. Hoffmann La Roche and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2021, Bioventus Inc., an active healing innovator company, announced the completion of the acquisition of Misonix Inc., regenerative medicine and minimally invasive therapeutic ultrasonic technologies provider developed for better clinical outcomes.

Anika Therapeutics Inc.

Overview: Anika Therapeutics is a company of joint preservation that provides a variety of advancements in orthopedic care early intervention. They provide solutions for soft tissue repair, osteoarthritis pain management, bone-preserving joint technologies, and regenerative therapeutics.

Product Portfolio:

Cingal: This is the first combination viscosupplement approved that provides both cross-linked hyaluronic acid as well as fast-acting steroid advantages for the treatment of osteoarthritis-associated symptoms. It combines Anika's Monovisc HA formulation with triamcinolone hexacetonide, an FDA-approved steroid for treating inflammation and relieving pain.

Key Development: In Jan 2020, Anika Therapeutics Inc., an integrated company of regenerative therapies and joint preservation with products supporting its hyaluronic acid technology platform, announced its acquisition agreement with Parcus Medical, a company of sports medicine and Arthrosurface, a solution provider for joint surface and preservation.

The global viscosupplementation market report would provide access to approx. 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence & incidence of osteoarthritis
      • 4.1.1.2. Increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Associated Adverse Effects
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis
  • 5.5 Epidemiology

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Procedure Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 7.1.2. Market Attractiveness Index, By Procedure Type
  • 7.2. Single Injection *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Three Injection
  • 7.4. Five Injection

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Knee Osteoarthritis *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Hip Osteoarthritis
  • 8.4. Shoulder Osteoarthritis
  • 8.5. Ankle Osteoarthritis

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Orthopedic Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Hospitals
  • 9.4. Ambulatory Surgical Centres

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Anika Therapeutics, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Seikagaku Corporation
  • 12.3. Bioventus Inc.
  • 12.4. Johnson and Johnson
  • 12.5. Zimmer Biomet
  • 12.6. Sanofi S.A.
  • 12.7. Miravo Healthcare
  • 12.8. Aptissen
  • 12.9. L.G. Chem and Lifesciences Ltd
  • 12.10. F. Hoffmann La Roche

LIST NOT EXHAUSTIVE

13. Global Viscosupplementation Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us